Annecy, France

Claire Abadie

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Claire Abadie: Innovator in Ocular Therapeutics

Introduction

Claire Abadie is a prominent inventor based in Annecy, France, known for her significant contributions to the field of ocular therapeutics. With a total of four patents to her name, she has focused her research on innovative treatments for inflammatory eye diseases. Her work has the potential to greatly impact the lives of individuals suffering from various ocular conditions.

Latest Patents

One of Claire Abadie's latest patents involves the use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases. This invention refers to the use of protein kinase inhibitors, specifically targeting the c-Jun amino terminal kinase (JNK) with (poly-)peptides, chimeric peptides, or nucleic acids encoding these inhibitors. The patent outlines pharmaceutical compositions that can treat a range of inflammatory diseases affecting the eye, including hordeolum, chalazion, conjunctivitis, keratitis, and uveitis, among others. Another notable patent focuses on the protein SLURP-1 for use in the treatment of ocular diseases. This invention relates to a protein comprising SEQ ID NO:1 (the mature form of SLURP-1) and its composition for inducing or accelerating cicatrization and preventing infection in the eye.

Career Highlights

Throughout her career, Claire Abadie has worked with various companies, including Xigen Inflammation Ltd. and Ribovax Biotechnologies S.A. Her innovative research and dedication to improving ocular health have established her as a key figure in the biotechnology sector.

Collaborations

Claire has collaborated with notable professionals in her field, including Jean-Marc Combette and Catherine Deloche. These partnerships have further enhanced her research and development efforts in ocular therapeutics.

Conclusion

Claire Abadie is a trailblazer in the field of ocular therapeutics, with her patents paving the way for new treatments for inflammatory eye diseases. Her contributions to the industry reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…